Echocardiographic assessment of residuals after transvenous intracardiac lead extraction
- 16 November 2019
- journal article
- research article
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 36 (3) , 423-430
Abstract
Detection of residual fibrotic tissue, called ghosts, after lead extraction is a new phenomenon in cardiology. This paper aims at describing the phenomenon of ghosts and determining their characteristic features. The study group consisted of 580 consecutive patients who underwent transvenous lead extraction (TLE) due to local infection, endocarditis and a superfluous lead. Each patient was clinically examined with the application of transthoracic echocardiography and transesophageal echocardiography directly before and after TLE. In the study population ghosts were detected in 110 patients (19%), and in 470 cases (81%) fibrotic tissue residuals were not found. Ghosts were most often located along the originally implanted lead’s route. Longer ghosts were found after the removal of cardiac resynchronization therapy (CRT) and dual chamber pacing (DDD) devices. The local infection and infective endocarditis are associated with a larger number of ghosts revealed after the removal procedure (p = 0.006). The type of the implanted device: CRT/ICD/double chamber pacemaker/single chamber pacemaker, similar to the number of leads, did not impact on the number of the detected ghosts. The relationship between abrasions of the leads and the presence of ghosts proved significant, however (p = 0.043). TLE is associated with the presence of fibrotic tissue residuals in approx. 19% of patients. Indications for lead extraction due to local infection and endocarditis yielded significantly more cases of ghosts than in the entire patient population. The presence of abrasions is a good predictor for the presence of ghosts on the leads.Keywords
This publication has 20 references indexed in Scilit:
- 'Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper' [Europace 2012;14:124-134. doi: 10.1093/europace/eur338]EP Europace, 2012
- Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paperEP Europace, 2011
- Histological findings around electrodes in pacemaker and implantable cardioverter-defibrillator patients: comparison of steroid-eluting and non-steroid-eluting electrodesEP Europace, 2011
- Prevalence of tricuspid regurgitation and pericardial effusions following pacemaker and defibrillator lead extractionInternational Journal of Cardiology, 2010
- Extraction of cardiac rhythm devices: indications, techniques and outcomes for the removal of pacemaker and defibrillator leadsInternational Journal Of Clinical Practice, 2010
- Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extractionEP Europace, 2009
- Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient ManagementHeart Rhythm, 2009
- Predictors of Complications of Endovascular Chronic Lead Extractions from Pacemakers and Defibrillators: A Single‐Operator ExperienceJournal of Cardiovascular Electrophysiology, 2009
- Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leadsEuropean Heart Journal, 2008
- Residual fibrous tissue floating in the right atrium after percutaneous pacemaker lead extraction: An unusual complication early detected by intracardiac echocardiographyInternational Journal of Cardiology, 2008